Reduced paraoxonase 1 activities may explain the comorbidities between temporal lobe epilepsy and depression, anxiety and psychosis

doi:10.5498/wjp.v12.i2.308

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4527)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

252

WORD

121

HTML

1935

Figures (1-3)

541

Tables (1-5)

347

Sum=3196

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

453

Download

878

Sum=1331

Feb 19, 2022 (publication date) through Jan 14, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Psychiatry. Feb 19, 2022; 12(2): 308-322
Published online Feb 19, 2022. doi: 10.5498/wjp.v12.i2.308

Full Size Figure Download Figure

Figure 1 Box plot of 4-(chloromethyl) phenyl acetate hydrolysis activity in controls (0), pure temporal lobe epilepsy (temporal lobe epilepsy: No comorbidities are present) and temporal lobe epilepsy with psychiatric comorbidities. TLE: Temporal lobe epilepsy; CMPAase: 4-(chloromethyl)phenyl acetate hydrolysis.

Citation: Michelin AP, Maes MHJ, Supasitthumrong T, Limotai C, Matsumoto AK, de Oliveira Semeão L, de Lima Pedrão JV, Moreira EG, Kanchanatawan B, Barbosa DS. Reduced paraoxonase 1 activities may explain the comorbidities between temporal lobe epilepsy and depression, anxiety and psychosis. World J Psychiatry 2022; 12(2): 308-322
URL: https://www.wjgnet.com/2220-3206/full/v12/i2/308.htm
DOI: https://dx.doi.org/10.5498/wjp.v12.i2.308